Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gyrolab is a life science tools business focused on automated nanoliter-scale immunoassay systems used in biopharma research, drug development, and bioprocess testing. The company is best known for the Gyrolab platform, which uses microfluidic CDs and automated workflows to run ligand-binding and biomarker assays with low sample consumption and relatively high throughput. Its systems and consumables are used for applications such as pharmacokinetics, immunogenicity, cytokine analysis, and process development rather than for developing therapeutic drugs of its own. Gyrolab has operated as part of Gyros Protein Technologies and is associated with the broader Standard BioTools portfolio following corporate acquisitions and integration activity. Overall, it is best characterized as a commercial life science instrumentation and assay platform business serving biopharma and academic laboratories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gyrolab.